<DOC>
	<DOCNO>NCT01382992</DOCNO>
	<brief_summary>EGFR mutation play essential role EGFR-TKIs treatment . However , patient , tissue sample available . The purpose study determine whether blood sample feasible EGFR mutation detection.For late stage NSCLC , hypothesis plasma sample alternative detect EGFR mutation .</brief_summary>
	<brief_title>A Retrospective EGFR Mutation Status Study Chinese NSCLC Patients Using Paired Plasma Tissue Samples</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria>Nonsmall cell lung cancer Available plasma pathologically confirm tissue slice ( prechemo preradio therapy ) Informed Consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>Carcinoma , Non-Small-Cell Lung</keyword>
	<keyword>erbB-1</keyword>
</DOC>